IDEXX Laboratories (NASDAQ:IDXX) Sets New 1-Year Low – Here’s Why

IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares reached a new 52-week low during trading on Wednesday . The company traded as low as $515.86 and last traded at $519.3270, with a volume of 24987 shares changing hands. The stock had previously closed at $520.21.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on IDXX. UBS Group increased their price objective on IDEXX Laboratories from $620.00 to $670.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 5th. Citigroup upped their target price on IDEXX Laboratories from $650.00 to $670.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 5th. Wall Street Zen cut IDEXX Laboratories from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Weiss Ratings downgraded IDEXX Laboratories from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Finally, Barclays cut their price objective on IDEXX Laboratories from $800.00 to $710.00 and set an “overweight” rating for the company in a report on Tuesday, August 11th. Six analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $747.00.

IDEXX Laboratories Stock Performance

The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.87 and a current ratio of 1.17. The stock has a market cap of $41.03 billion, a PE ratio of 36.59, a PEG ratio of 2.86 and a beta of 1.54. The company’s 50-day moving average price is $558.13 and its two-hundred day moving average price is $568.61.

IDEXX Laboratories (NASDAQ:IDXX) last announced its earnings results on Tuesday, August 4th. The company reported $4.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.94 by $0.33. The company had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.20 billion. IDEXX Laboratories had a net margin of 25.03% and a return on equity of 71.96%. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same period in the previous year, the business earned $3.50 earnings per share. IDEXX Laboratories has set its FY 2026 guidance at 14.690-14.940 EPS. On average, equities research analysts forecast that IDEXX Laboratories, Inc. will post 14.81 EPS for the current year.

Hedge Funds Weigh In On IDEXX Laboratories

Several institutional investors and hedge funds have recently made changes to their positions in IDXX. J.Safra Asset Management Corp bought a new stake in IDEXX Laboratories in the second quarter worth $25,000. SHP Wealth Management bought a new position in shares of IDEXX Laboratories during the fourth quarter valued at about $26,000. Elevation Wealth Partners LLC grew its stake in shares of IDEXX Laboratories by 188.2% during the second quarter. Elevation Wealth Partners LLC now owns 49 shares of the company’s stock valued at $26,000 after buying an additional 32 shares during the last quarter. Virtus Advisers LLC purchased a new position in shares of IDEXX Laboratories in the third quarter worth about $26,000. Finally, WealthCollab LLC purchased a new position in shares of IDEXX Laboratories in the second quarter worth about $30,000. Institutional investors own 87.84% of the company’s stock.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops and provides diagnostic, information technology and water-testing products and services. The company primarily serves the companion-animal veterinary market, offering laboratory and in-clinic diagnostic testing, analyzers, consumables, digital imaging solutions and veterinary practice-management software. Its products help veterinarians diagnose and monitor diseases, manage patient records and improve clinical workflows.

IDEXX also provides testing products and services for livestock and poultry health, as well as microbiology testing solutions for water quality.